Testosterone Treatment Does Not Reduce Fracture Risk in Men with Hypogonadism; Fracture occurrences were numerically higher among men who received testosterone than placebo across a subtrial of the phase 4 TRAVERSE trial.

Press/Media

PeriodJan 17 2024

Media coverage

2

Media coverage

  • TitleTestosterone Treatment Does Not Reduce Fracture Risk in Men with Hypogonadism; Fracture occurrences were numerically higher among men who received testosterone than placebo across a subtrial of the phase 4 TRAVERSE trial.
    Media name/outletConsultant Live
    Country/TerritoryUnited States
    Date01/17/24
    PersonsSuzanne M. Miller
  • TitleTestosterone Treatment Does Not Reduce Fracture Risk in Men with Hypogonadism
    Media name/outletHCP Live
    Country/TerritoryUnited States
    Date01/17/24
    PersonsSuzanne M. Miller